Understanding How Young Adults Perceive Blurred Image Quality and Creating a Model Predicting Their Quality Ratings
GESUVIPE
Modèle de Performance Subjective Généralisé
2 other identifiers
interventional
20
1 country
1
Brief Summary
This clinical study wants to understand how blurred images look to young adults. The main question is: How do different kinds of images and different kinds of blur change the way people think those images look? Participants will get an eye exam, then look at several blurred images and rate how good or bad each one looks on a quality scale from 1 (very bad) to 10 (very good).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2026
CompletedFirst Submitted
Initial submission to the registry
February 2, 2026
CompletedFirst Posted
Study publicly available on registry
February 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedFebruary 11, 2026
February 1, 2026
3 months
February 2, 2026
February 9, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Subjective image quality rating on a quality scale from 1 (very bad) to 10 (very good)
Day one
Study Arms (1)
single arm
EXPERIMENTALyoung adults that are provided with simulated images to be observed and rated
Interventions
participants will have to rate the perceived quality of images on a 10 points scale
Eligibility Criteria
You may qualify if:
- Distance refractive error (equivalent sphere) between -7 D and +5 D
- Astigmatism below 4D
- Minimum corrected visual acuity: 10/10
You may not qualify if:
- Aphakic or pseudophakic eye surgery
- Reported systemic pathology that affects vision
- Medical treatment or taking medications that affect vision
- Severe ocular pathology declared, involving a loss of visual field as in glaucoma, a loss of acuity
- Reported neurological deficit, including a history of seizure or sensorimotor coordination disorders, vestibular or cerebellar pathology
- Binocular vision problems such as amblyopia, strabismus, or double vision
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
LABORATOIRE LuMIn - ENS Paris-Saclay
Gif-sur-Yvette, 91190, France
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2026
First Posted
February 9, 2026
Study Start
February 1, 2026
Primary Completion
May 1, 2026
Study Completion
May 1, 2026
Last Updated
February 11, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share